List of Excipients in API GLUCAGON
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing GLUCAGON
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Eli Lilly and Company | BAQSIMI | glucagon | 0002-6145 | ACETIC ACID | |
Eli Lilly and Company | BAQSIMI | glucagon | 0002-6145 | BETADEX | |
Eli Lilly and Company | BAQSIMI | glucagon | 0002-6145 | DODECYLPHOSPHOCHOLINE | |
Eli Lilly and Company | BAQSIMI | glucagon | 0002-6145 | WATER | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for GLUCAGON
Excipient focus: ACETIC ACID
GLUCAGON drug variants containing ACETIC ACID
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | glucagon | 0002-6145 |
Amphastar Pharmaceuticals Inc | glucagon | 0548-8351 |
>Company | >Ingredient | >NDC |
GLUCAGON drug variants not containing ACETIC ACID
Company | Ingredient | NDC |
---|---|---|
Fresenius Kabi USA LLC | glucagon | 63323-596 |
Xeris Pharmaceuticals Inc | glucagon injection, solution | 72065-130 |
>Company | >Ingredient | >NDC |
Excipient focus: BETADEX
GLUCAGON drug variants containing BETADEX
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | glucagon | 0002-6145 |
Amphastar Pharmaceuticals Inc | glucagon | 0548-8351 |
>Company | >Ingredient | >NDC |
GLUCAGON drug variants not containing BETADEX
Company | Ingredient | NDC |
---|---|---|
Fresenius Kabi USA LLC | glucagon | 63323-596 |
Xeris Pharmaceuticals Inc | glucagon injection, solution | 72065-130 |
>Company | >Ingredient | >NDC |
Excipient focus: DIMETHYL SULFOXIDE
GLUCAGON drug variants containing DIMETHYL SULFOXIDE
Company | Ingredient | NDC |
---|---|---|
Xeris Pharmaceuticals Inc | glucagon injection, solution | 72065-130 |
>Company | >Ingredient | >NDC |
GLUCAGON drug variants not containing DIMETHYL SULFOXIDE
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | glucagon | 0002-6145 |
Amphastar Pharmaceuticals Inc | glucagon | 0548-8351 |
Fresenius Kabi USA LLC | glucagon | 63323-596 |
>Company | >Ingredient | >NDC |
Excipient focus: DODECYLPHOSPHOCHOLINE
GLUCAGON drug variants containing DODECYLPHOSPHOCHOLINE
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | glucagon | 0002-6145 |
Amphastar Pharmaceuticals Inc | glucagon | 0548-8351 |
>Company | >Ingredient | >NDC |
GLUCAGON drug variants not containing DODECYLPHOSPHOCHOLINE
Company | Ingredient | NDC |
---|---|---|
Fresenius Kabi USA LLC | glucagon | 63323-596 |
Xeris Pharmaceuticals Inc | glucagon injection, solution | 72065-130 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
GLUCAGON drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Fresenius Kabi USA LLC | glucagon | 63323-596 |
>Company | >Ingredient | >NDC |
GLUCAGON drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | glucagon | 0002-6145 |
Amphastar Pharmaceuticals Inc | glucagon | 0548-8351 |
Xeris Pharmaceuticals Inc | glucagon injection, solution | 72065-130 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
GLUCAGON drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Fresenius Kabi USA LLC | glucagon | 63323-596 |
>Company | >Ingredient | >NDC |
GLUCAGON drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | glucagon | 0002-6145 |
Amphastar Pharmaceuticals Inc | glucagon | 0548-8351 |
Xeris Pharmaceuticals Inc | glucagon injection, solution | 72065-130 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
GLUCAGON drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Fresenius Kabi USA LLC | glucagon | 63323-596 |
>Company | >Ingredient | >NDC |
GLUCAGON drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | glucagon | 0002-6145 |
Amphastar Pharmaceuticals Inc | glucagon | 0548-8351 |
Xeris Pharmaceuticals Inc | glucagon injection, solution | 72065-130 |
>Company | >Ingredient | >NDC |
Excipient focus: SULFURIC ACID
GLUCAGON drug variants containing SULFURIC ACID
Company | Ingredient | NDC |
---|---|---|
Xeris Pharmaceuticals Inc | glucagon injection, solution | 72065-130 |
>Company | >Ingredient | >NDC |
GLUCAGON drug variants not containing SULFURIC ACID
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | glucagon | 0002-6145 |
Amphastar Pharmaceuticals Inc | glucagon | 0548-8351 |
Fresenius Kabi USA LLC | glucagon | 63323-596 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
GLUCAGON drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Eli Lilly and Company | glucagon | 0002-6145 |
Amphastar Pharmaceuticals Inc | glucagon | 0548-8351 |
>Company | >Ingredient | >NDC |
GLUCAGON drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Fresenius Kabi USA LLC | glucagon | 63323-596 |
Xeris Pharmaceuticals Inc | glucagon injection, solution | 72065-130 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.